SecSonar.com

Aditxt, Inc. (ADTX)

Aditxt, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Aditxt, Inc. (ADTX) is a Biotechnology company based in US with a market capitalization of $4K. Revenue declined 97.6% year-over-year and free cash flow was negative at -$25.7B. This page tracks ADTX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 26 employees · IPO Jun 30, 2020

Valuation

Valuation & price

$0.51 · as of May 23, 2026 · -100.0% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.00

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$30.0K$15.0K$0.00Jul 25Dec 25Jul 26Jul 7, 25$27336.96Jul 9, 25$29533.68Jul 11, 25$29289.60Jul 15, 25$28557.36Jul 17, 25$29533.68Jul 21, 25$28801.44Jul 23, 25$30021.84Jul 25, 25$29045.52Jul 29, 25$28069.20Jul 31, 25$26604.72Aug 4, 25$24103.44Aug 6, 25$26604.72Aug 11, 25$27581.04Aug 13, 25$25628.40Aug 15, 25$24896.16Aug 19, 25$26604.72Aug 21, 25$25140.24Aug 25, 25$25628.40Aug 27, 25$26116.56Aug 29, 25$25140.24Sep 3, 25$24289.20Sep 5, 25$22816.08Sep 9, 25$26116.56Sep 11, 25$26116.56Sep 16, 25$25384.32Sep 18, 25$24652.08Sep 22, 25$25140.24Sep 24, 25$24207.12Sep 26, 25$20615.04Sep 30, 25$18360.00Oct 2, 25$18550.08Oct 6, 25$16735.68Oct 8, 25$16914.96Oct 10, 25$14675.04Oct 14, 25$11603.52Oct 16, 25$10290.24Oct 21, 25$7177.68Oct 23, 25$7298.64Oct 27, 25$4734.72Oct 29, 25$2795.04Oct 31, 25$1449.36Nov 4, 25$1123.20Nov 6, 25$1272.24Nov 10, 25$1233.36Nov 12, 25$1352.16Nov 14, 25$1045.44Nov 18, 25$881.28Nov 20, 25$619.92Nov 25, 25$568.08Nov 28, 25$820.80Dec 2, 25$535.68Dec 4, 25$628.56Dec 8, 25$702.00Dec 10, 25$550.80Dec 12, 25$483.84Dec 16, 25$306.72Dec 18, 25$272.16Dec 22, 25$263.52Dec 24, 25$246.24Dec 29, 25$222.48Jan 2, 26$191.16Jan 6, 26$190.62Jan 8, 26$180.63Jan 12, 26$176.04Jan 14, 26$157.68Jan 16, 26$187.92Jan 21, 26$315.36Jan 23, 26$252.72Jan 27, 26$208.98Jan 29, 26$177.12Feb 2, 26$172.26Feb 4, 26$142.56Feb 9, 26$151.74Feb 11, 26$149.58Feb 13, 26$133.38Feb 18, 26$126.63Feb 20, 26$109.62Feb 24, 26$112.05Feb 26, 26$103.68Mar 2, 26$103.68Mar 4, 26$102.60Mar 6, 26$100.44Mar 10, 26$73.71Mar 12, 26$78.03Mar 17, 26$39.96Mar 19, 26$33.75Mar 23, 26$29.16Mar 25, 26$24.57Mar 27, 26$21.87Mar 31, 26$26.43Apr 2, 26$21.45Apr 7, 26$14.03Apr 9, 26$14.31Apr 13, 26$12.68Apr 15, 26$12.07Apr 17, 26$11.73Apr 22, 26$8.37Apr 24, 26$7.63Apr 28, 26$5.90Apr 30, 26$5.27May 4, 26$3.78May 6, 26$3.65May 8, 26$3.21May 12, 26$2.30May 14, 26$1.80May 18, 26$1.63May 20, 26$1.40May 22, 26$0.51May 28, 26$0.16Jun 1, 26$0.11Jun 3, 26$0.09Jun 5, 26$0.06Jun 9, 26$0.03Jun 11, 26$0.01Jun 15, 26$0.01Jun 17, 26$0.00Jun 22, 26$0.02Jun 24, 26$0.01Jun 26, 26$0.00Jul 2, 26$0.01
$0.0052-week range$30754.08
Loading valuation history…

Fundamentals

Key fundamentals

$4K

Market cap

-97.6%

Revenue growth (YoY)

8.4%

Gross margin

-$25.7B

Free cash flow (USD)

-$192.1M

Net debt

Net cash position

232.1%

Share dilution

1/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$0.00FY 2018$0.00FY 2019$0.00FY 2020$0.00FY 2021$105.0KFY 2022$933.7KFY 2023$645.2KFY 2024$134.0KFY 2025$3.2K
$0$3.2K

Free cash flow by year

2017 → 2025

FY 2017$0.00FY 2018$-386.3KFY 2019$-464.4KFY 2020$-7.4MFY 2021$-23.3MFY 2022$-22.8MFY 2023$-18.6MFY 2024$-16.8MFY 2025$-25.7B
$0-$25.7B

Gross margin by year

2021 → 2025

FY 202125.8%FY 202217.9%FY 2023-17.3%FY 2024-367.9%FY 20258.4%
25.8%8.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

6

Insider buys · 90 days

7

Insider sells · 90 days

Earnings

Last reported: May 20, 2026 (EPS $-2.06)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $68KTakeover Time 2026 LLC · 10% Owner · $68.4KJun 25, 2026Filing
  • Insider buyInsider Buy $95KHRT FINANCIAL LP · 10% Owner · $95.4KJun 24, 2026Filing
  • 8-K eventDelisting NoticeJun 24, 2026Filing
  • 8-K eventNote Purchase Agreement AmendmentJun 23, 2026Filing
  • Insider sellInsider Sell $1KDRW Securities, LLC · 10% Owner · $1KJun 18, 2026Filing
  • Insider sellInsider Sell $41KHRT FINANCIAL LP · 10% Owner · $40.7KJun 18, 2026Filing
  • Insider buyInsider Buy $30KHRT FINANCIAL LP · 10% Owner · $29.6KJun 17, 2026Filing
  • Insider buyInsider Buy $68KHRT FINANCIAL LP · 10% Owner · $68KJun 16, 2026Filing
  • Insider sellInsider Sell $0BANK OF AMERICA CORP /DE/ · 10% Owner · $0.2Jun 15, 2026Filing
  • Insider sellInsider Sell $40KHRT FINANCIAL LP · 10% Owner · $39.7KJun 12, 2026Filing

Questions

Frequently asked questions

What is Aditxt, Inc.'s market cap?

Aditxt, Inc. (ADTX) has a market capitalization of $4K.

What is ADTX's P/E ratio?

A meaningful P/E ratio is not available for ADTX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is ADTX's price-to-book (P/B) ratio?

ADTX trades at 0.00 times book value per share.

When did Aditxt, Inc. last report earnings?

ADTX last reported earnings on May 20, 2026; the next date is not yet scheduled.

Are insiders buying ADTX stock?

Yes — SEC Form 4 filings show 6 open-market insider buys and 7 sells at Aditxt, Inc. in the last 90 days.

Same arena

Related companies in Biotechnology

GRI

GRI Bio, Inc.

$189.5K

JAGX

Jaguar Health, Inc.

$211.9K

NXTS

N2OFF, Inc.

$333.3K

PPBT

Purple Biotech Ltd.

$396K

ONCO

Onconetix, Inc.

$400.8K

SPRC

SciSparc Ltd.

$523.4K

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.